Funding Opportunities in Cancer Research
For assistance with funding, contact:
Paige Isom, Project Manager,
Funding and Awards
FUNDING OPPORTUNITY SEARCH TOOLS
Siteman Cancer Center — Internal
|December deadlines; see individual grant guidelines on link
||NEW: AACR Funding Opportunities for Postdoctoral or Clinical Research Fellows in Lymphoma, Prostate Cancer, and Melanoma
|| $50- 55,000 for one year
||The fellowship provides a one-year grant of $50,000 - $55,000 to support the salary and benefits of the fellow while working on targeted research projects. See individual award guidelines.
|INTERNAL COMPETITION: Jan. 2, 2014
||Alvin J. Siteman Cancer Research Fund
||This mechanism is intended to support innovative, translational research projects that have the promise of transforming cancer prevention, diagnosis, or treatment.
|Feb. 1, 2014
||NEW: Pardee Foundation Cancer Research Grant
|| Elsa U. Pardee Foundation
||Pardee Foundation grants are devoted to innovative approaches to conquering cancer, in particular they look to fund new scientist with cutting-edge ideas. Click to see previous awardees and amounts.
|INTERNAL COMPETITION: Feb. 12, 2014
||V Foundation Translational Clinical Research Grant Program
||V Foundation for Cancer Research
||$600,000 over 3 years
||Washington University anticipates being invited to submit one application. The purpose of these grants is to develop novel approaches to the prevention, detection and treatment of human cancer that requires collaboration of investigators from both lab and clinic. Project team must have a minimum of two scientists; project must not be funded by other mechanisms external to the SCC.
|NO Internal Competition as previously stated. (No longer required by this Foundation): Feb. 17, 2014
||Damon Runyon Cancer Clinical Investigator Award
||Damon Runyon Cancer Research Foundation
||$450,000 over 3 years
||This award is intended to provide outstanding young physicians with the resources and training structure essential to becoming independent clinical investigators.